When the daughter of Hyderabad resident Rahul Vipparathi was diagnosed with Tuberous Sclerosis Complex (TSC), a rare genetic disorder causing the growth of numerous benign tumours, it felt like his entire world had come crashing down. As a parent, one is expected to be the anchor during a storm, but...
Latest News
CAMBRIDGE, Mass. — PatientsLikeMe, the first community-based personalized medicine platform for people with life-changing conditions, and 23andMe, the world’s leading personal genomics company, announce a partnership today to help people with Parkinson’s disease. PatientsLikeMe is teaming with 23andMe on its effort to recruit 10,000 people with Parkinson’s for a massive...
Aargau, Switzerland – In the treatment of cancer patients, irradiation can be adapted anew each day to the position of the tumour and conditions in the body. Researchers at the Paul Scherrer Institute PSI have now, for the first time, integrated such a workflow into everyday clinical practice in proton...
Oslo, Norway – PCI Biotech Holding ASA (OSE: PCIB), a cancer-focused biopharmaceutical company with a unique intracellular delivery technology via Photochemical Internalisation and Immunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on hard-to-treat established tumors and the prevention of cancer recurrence, announced today an extension of their current collaboration. The companies jointly research...
Oslo – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that the Ministry of Food and Drug Safety (MFDS) in South Korea has granted Orphan Drug Designation to its lead product candidate, fimaporfin, for combination treatment with gemcitabine in patients with inoperable locally advanced or metastatic bile...
Oslo (Norway) – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced that the first US patient has been enrolled into the fimaChem pivotal RELEASE study with registration intent in inoperable bile duct cancer patients. The RELEASE study...
WASHINGTON – Patients, clinicians and families facing uncertainty about their choices for managing Type 2 diabetes and rare diseases will gain new evidence to inform their decision making from comparative clinical effectiveness research (CER) studies that the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved for a total...
Los Angeles, Calif. – The Pediatric Cancer Research Foundation today announced a call for entries for its 2024 Cancer Survivor Scholarships. The Foundation will award $100,000 to eligible students – including graduating high school seniors, college, vocational and graduate students – to support these students in realizing happy, productive futures....
FRANKFURT, Germany – The term ‘leukemia’ encompasses various forms of blood cancer, including acute myeloid leukemia (AML). In AML, blood cells in the early stages – the stem cells and the precursor cells that develop out of them – degenerate. AML is the second most common leukemia in children, accounting...
PHILADELPHIA, PA — Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals’ genetic ancestry. PKU causes an amino acid—called phenylalanine (Phe)—to build up in the bloodstream. Uncontrolled PKU can lead to intellectual disability, psychiatric issues, and...